Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlus500 Regulatory News (PLUS)

Share Price Information for Plus500 (PLUS)

Share Price is delayed by 15 minutes
Get Live Data
4,148.00    -790.00 (-16.00%)
Bid:
4,144.00
Ask:
4,154.00
Spread: 10.00 (0.241%)
Market Cap: £2.87b
PLUS Live PriceLast checked at - London Stock Exchange

Intraday Plus500 Share Chart

Half Year 2026 Trading Update

Today 07:00

RNS Number : 0506M
Plus500 Limited
13 July 2026
 

13 July 2026

Plus500 Ltd.

("Plus500", the "Company" or, together with its subsidiaries, the "Group")

H1 2026 Trading Update

Record[1] H1 2026 performance: Customer Income up 24% YoY to $460.8m and Revenue up 12% YoY to $462.9m

FY 2026 revenue and EBITDA reconfirmed, following multiple upgrades to market expectations[2] this year

Plus500, a global multi-asset fintech group operating proprietary technology-based trading platforms, today announces its trading update for the six-month period ended 30 June 2026.

David Zruia, Chief Executive Officer of Plus500, commented:

"H1 2026 delivered the strongest Customer Income in five years and the highest revenue in three years, reflecting the quality of our customer base, the power of our proprietary technology, and the growing breadth of our global platforms.

In the US, we launched our B2C prediction markets offering in February 2026 and recently introduced our next-generation offering with CFTC-regulated sports event-based contracts, the highest-engagement category in prediction markets. We will continue to leverage our unique dual-channel position across B2B and B2C segments to drive growth, innovation and partnerships. In our OTC business, we launched our localised trading platform in Canada and also introduced innovative new products for our global customer base to continuously access market opportunities across stocks and ETFs.

This strong performance reflects Plus500's strategic evolution into a diversified, global multi-asset fintech group, with a more resilient and diversified earnings model. The Board expects FY 2026 revenue and EBITDA to be in-line with current market expectations, following several upgrades this year."

Financial and Operational highlights*

H1 2026

H1 2025

Change %

Q2 2026

Q2 2025

Change %

Revenue[3]

$462.9m

$415.1m

12%

$220.8m

$209.3m

5%

EBITDA[4]

$187.5m

$185.1m

1%

$91.8m

$91.3m

1%

ARPU[5]

$2,346

$2,307

2%

$1,683

$1,578

7%

*Unaudited

Material strategic expansion into high-growth markets and next-generation products

+ Plus500 has established itself at the centre of the US prediction markets industry, one of the most dynamic and fast-growing segments in the financial markets today, significantly expanding the Group's addressable market. In February 2026, the Group launched its B2C prediction markets offering and, in June 2026, launched its next-generation offering with CFTC-regulated sports event-based contracts, representing the highest-engagement category in prediction markets.

+ Both the Group's OTC and non-OTC[6] businesses delivered strong financial performance in H1 2026. The global OTC offering expansion into Canada and Japan continued to broaden an already resilient and diversified global earnings base. North America expansion is gathering momentum, with Canada now live on Plus500's localised OTC platform. In Japan, the enhanced multi-asset product offering, tailored for the local market, is providing further momentum to this important long-term growth opportunity.

+ The Group launched 24/5 trading on stocks and ETFs, enabling customers to trade around the clock, five days a week, and further expanding the Group's OTC product offering with continuous access to global financial markets. This reflects a structural shift reshaping the industry, with extended-hours trading now accounting for a significant and growing share of global retail activity.

 

Record performance reflects strength and depth of the Plus500 platforms

+ Customer Income[7] reached a five-year record high for a six-month period of $460.8m, a 24% increase year-on-year ("YoY") (H1 2025: $371.5m), demonstrating the accelerating momentum across the Group and the increasingly high value and growing longevity of its customers.

+ Revenue increased by 12% YoY to $462.9m (H1 2025: $415.1m), reaching a three-year record high, driven by strong performance across all business lines and the continued structural diversification of the Group's earnings base. This performance was further supported by heightened market volatility, which Plus500's scalable, proprietary technology platforms were well positioned to capitalise on.

+ EBITDA increased by 1% YoY to $187.5m (H1 2025: $185.1m), equating to an EBITDA margin of 41%, reflecting the flexibility of the Group's operating cost base and its ability to invest in growth while maintaining strong profitability. During H1 2026, the Group deliberately increased investment in customer acquisition, driving a 17% increase in New Customers[8] YoY, alongside strategic initiatives to attract higher value customers and support the expansion of the Group's US operations. On a constant currency basis, underlying performance was even stronger, with reported results impacted by FX-related cost headwinds during the period.

+ The non-OTC business accounted for c.15% of total Group revenue in H1 2026 (H1 2025: c.13%), equating to c.$70m and representing growth of c.30% YoY, with accelerating momentum across the US businesses. This performance highlights the continued and increasingly diversified composition of the Group's revenue mix.

+ New Customers reached 65,723 in H1 2026, a 17% increase YoY (H1 2025: 56,165), including 25,856 in Q2 2026 (Q2 2025: 29,268), supporting Active Customers[9] of 197,294, which increased by 10% YoY (H1 2025: 179,931), including 131,214 in Q2 2026 (Q2 2025: 132,602).

+ The Group's deliberate focus on higher-value customers with greater longevity, enabled by the continued strength of its proprietary technology and compelling product offering, is directly reflected in the five-year record Customer Income and the increasing strength and resilience of the Group's revenue and earnings.

+ The Group's balance sheet remained debt-free with cash balances of over $850m as of 30 June 2026.

Outlook

Plus500 enters H2 2026 with strong operational momentum and with a broader, deeper and more competitively differentiated strategic roadmap across both its OTC and non-OTC businesses. The continued scaling of the Group's US operations, including its expanding prediction markets offering, provides a fast-growing and increasingly significant growth opportunity, alongside the OTC business that continues to demonstrate resilience and depth across global markets.

Supported by a robust, debt-free balance sheet, proven best-in-class proprietary technology and a growing pipeline of B2B and B2C opportunities, the Company's Board of Directors is confident in the Group's prospects and expects FY 2026 revenue and EBITDA to be in-line with current market expectations[10], following multiple upgrades this year.

Plus500 will announce its H1 2026 results, including new shareholder returns comprising dividends and share buyback programmes, on Monday 10 August 2026.

For further details:

Plus500 Ltd.

Elad Even-Chen, Chief Financial Officer

Owen Jones, Head of Investor Relations

+972 4 8189503

+44 (0) 7551 654208

ir@Plus500.com

 

FTI Consulting

Ed Berry

Dwight Burden

Victoria Hayns

+44 20 3727 1000

Plus500@fticonsulting.com

 

About Plus500

Plus500 is a global multi-asset fintech group operating proprietary technology-based trading platforms. Plus500 offers customers a range of trading products, including OTC ("Over-the-Counter" products, namely Contracts for Difference (CFDs)), share dealing, as well as futures and options on futures.

The Group retains operating licences and is regulated in the United Kingdom, Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, the Seychelles, the United States, Estonia, Japan, the UAE, the Bahamas, Canada, Colombia and India, and through its OTC product portfolio, offers more than 2,500 different underlying global financial instruments, comprising equities, indices, commodities, options, ETFs, foreign exchange and cryptocurrencies. Customers of the Group can trade its OTC products in more than 60 countries and in 30 languages.

Plus500's trading platforms are accessible from multiple operating systems (iOS, Android and Windows) and web browsers. Customer care is, and has always been, integral to Plus500. As such, OTC customers cannot be subject to negative balances. A free demo account is available on an unlimited basis for OTC trading platform users and sophisticated risk management tools are provided free of charge to manage leveraged exposure, and stop losses to help customers protect profits, while limiting capital losses.

Plus500 was admitted to trading on the London Stock Exchange (LON: PLUS) on 24 July 2013. It was admitted to the Equity Shares in Commercial Companies ("ESCC") Category of the Official List and is a constituent of the FTSE 250 Index and the STOXX Europe 600 Index. Website: www.plus500.com.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR"). Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Forward looking statements

This announcement contains statements that are or may be forward-looking statements. All statements other than statements of historical facts included in this announcement may be forward-looking statements, including statements that relate to the Group's future prospects, developments and strategies. The Company does not accept any responsibility for the accuracy or completeness of any information reported by the press or other media, nor the fairness or appropriateness of any forecasts, views or opinions express by the press or other media regarding the Group. The Company makes no representation as to the appropriateness, accuracy, completeness or reliability of any such information or publication.

Forward-looking statements are identified by their use of terms and phrases such as "believe", "targets", "expects", "aim", "anticipate", "project", "would", "could", "envisage", "estimate", "intend", "may", "plan", "will" or the negative of those, variations or comparable expressions, including references to assumptions. The forward-looking statements in this announcement are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements. Factors that may cause actual results to differ materially from those expressed or implied by such forward looking statements include, but are not limited to, those described in the Risk Management Framework section of the Company's most recent Annual Report. These forward-looking statements are based on numerous assumptions regarding the present and future business strategies of the Group and the environment in which it is and will operate in the future. All subsequent oral or written forward-looking statements attributed to the Company or any persons acting on its behalf are expressly qualified in their entirety by the cautionary statement above. Each forward-looking statement speaks only as of the date of this announcement. Except as required by law, regulatory requirement, the UK Listing Rules and the Disclosure Guidance and Transparency Rules, neither the Company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.


[1] Record six-month period for Customer Income over the last five years and for Revenue over the last three years

[2] Market expectations - Based on compiled analysts' consensus forecasts (Source: Bloomberg), located on the Investor Relations section of the Company's website. Consensus forecasts for FY 2026 Revenue and EBITDA are $811.5m and $368.1m, respectively

[3] Revenue is comprised of trading income and interest income

[4] EBITDA - Revenue (trading income and interest income) minus operating expenses plus depreciation and amortisation

[5] ARPU - Average Revenue Per User

[6] Non-OTC includes futures and share dealing

[7] Customer Income - From OTC (customer spreads and overnight charges) and non-OTC (commissions from the Group's futures and options on futures operation and from 'Plus500 Invest', the Group's share dealing platform)

[8] New Customers - Customers depositing for the first time

[9] Active Customers - Customers who made at least one real money trade during the period

[10] Market expectations - Based on compiled analysts' consensus forecasts (Source: Bloomberg), located on the Investor Relations section of the Company's website. Consensus forecasts for FY 2026 Revenue and EBITDA are $811.5m and $368.1m, respectively

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRTMLTMTMBBFF
Date   Source Headline
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSHalf Year 2025 Trading Update
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSDirector/PDMR Shareholding
23rd Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSNotification under UK Listing Rule 9.6.14(2)
23rd Jun 20257:00 amRNSPlus500 secures a new regulatory licence in Canada
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSHolding(s) in Company
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.